Avalo Therapeutics (NASDAQ:AVTX) is preparing to report phase IIb data in the second quarter of 2026 from its LOTUS trial evaluating AVTX-009 in hidradenitis suppurativa (HS), CEO Garry Neil said ...
Israel’s Teva Pharmaceutical Industries US unit and French pharma major Sanofi today announced positive results from the RELIEVE UCCD long-term extension (LTE) study of duvakitug, an investigational ...
Clinical Trials Arena on MSN
Lundbeck’s migraine prevention drug meets primary endpoint in Phase IIb trial
Lundbeck will advance the IV formulation of the drug to Phase III trials after the successful Phase IIb trial.
The low rate of intracranial hemorrhage in these trials suggests that, at least in the patient population included in clinical trials, there is no increased risk in comparison to control arms of ...
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children’s Oncology Group Study ANBL0531 A total of 223 patients (from ...
The International Investment Bank (IIB) says it will leave its headquarters in Budapest and return to Russia after the Hungarian government withdrew its representatives from the Moscow-led institution ...
JAXA: As a result of the successful launch of the H-IIB Launch Vehicle No. 3, the Japan Aerospace Exploration Agency (JAXA) and Mitsubishi Heavy Industries LTD. (MHI) have agreed to privatize the ...
NASA abandoned work toward piloted Mars and Venus flyby missions based on hardware developed for Apollo and its planned successor, the Apollo Applications Program, during the final months of the ...
The beneficial effects of glycoprotein IIb/IIIa receptor antagonists in preventing ischemic complications during percutaneous coronary intervention have been established in a series of controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results